Alternative and aberrant splicing of MDM2 mRNA in human cancer

This publication has 48 references indexed in Scilit:

• SHORT COMMUNICATION Novel mdm2 Splice Variants Identified in Pediatric Rhabdomyosarcoma Tumors and Cell Lines
  Oncology Research, 2001
• Amplification of themdm2 gene, but not expression of splice variants ofmdm2 mrna, is associated with prognosis in soft tissue sarcoma
  International Journal of Cancer, 2001
• The contribution of the acidic domain of MDM2 to p53 and MDM2 stability
  Oncogene, 2001
• The MDM2 Oncoprotein Promotes Apoptosis in p53-Deficient Human Medullary Thyroid Carcinoma Cells1
  Endocrinology, 2000
• Role of two upstream open reading frames in the translational control of oncogene mdm2
  Oncogene, 1999
• The human oncoprotein MDM2 arrests the cell cycle: elimination of its cell-cycle-inhibitory function induces tumorigenesis
  The EMBO Journal, 1998
• Abnormal expression of MDM-2 in breast carcinomas
  Breast Cancer Research and Treatment, 1996
• mdm-2 Inhibits the G₁ Arrest and Apoptosis Functions of the p53 Tumor Suppressor Protein
  Molecular and Cellular Biology, 1996
• Regulation of mdm2 expression by p53: alternative promoters produce transcripts with nonidentical translation potential.
  Genes & Development, 1994
• Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line
  Somatic Cell and Molecular Genetics, 1987